about
Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host diseaseNucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma.NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN ProductionSimultaneous deletion of NOD1 and NOD2 inhibits in vitro alloresponses but does not prevent allograft rejection.Gut bacteria drive Kupffer cell expansion via MAMP-mediated ICAM-1 induction on sinusoidal endothelium and influence preservation-reperfusion injury after orthotopic liver transplantationTumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus PolymeraseNOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.Phenotyping of Nod1/2 double deficient mice and characterization of Nod1/2 in systemic inflammation and associated renal disease.Direct recognition of LPS drive TLR4 expressing CD8+ T cell activation in patients with rheumatoid arthritis.Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine productionCigarette Smoking Triggers Colitis by IFN-γ+ CD4+ T Cells.Effect of muramyl peptides on mitochondrial respiration.NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload.New insights into Nod-like receptors (NLRs) in liver diseases.Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-κB, MMP-9 and up-regulated claudin-5 expression.
P2860
Q27314927-0F36D885-5A5B-408E-ABE0-10C77810202FQ34948378-0911BC42-B9A3-4317-9035-E6216E5FE519Q35226121-38A3C9FF-A5E4-4DCA-AD0E-C9722C11FC91Q35746343-661554A9-05CD-4BBE-A3B0-9283FD0CBC30Q36021322-1201D14A-E880-429E-ADE5-26A7CD943043Q36495202-EC448183-3192-4BB3-B8A6-626FE15FAFBFQ37544847-B74EF7FA-188C-41D0-B88E-414B432F1CA1Q38776629-B772C5CF-93F2-4AB1-85DC-AC742E812AE3Q40110488-8017CF7F-84BC-4D8C-BBA2-87B14134A1DFQ41872777-F7666A05-0CDA-4D61-8CF3-651321C1EC7CQ42193578-9CFEA4E8-C74F-4571-888A-9FB3AE38069BQ42450600-64A27443-E5FD-4826-A777-A86993835607Q45848920-8C3A66E4-F814-4176-BC3D-D77A27F215F5Q46201138-44AFFD4D-35C9-4A4C-93FC-3198588B3DDAQ47745538-A1B4B9DC-C563-4D07-B1AC-2E10549DC2E5Q52624393-E2CCC9B3-A7C0-4295-B538-C5588286D5B7Q54351625-93C0F185-2F2F-4C49-9ADA-4FAF19570963
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
NOD2: a potential target for regulating liver injury.
@en
NOD2: a potential target for regulating liver injury.
@nl
type
label
NOD2: a potential target for regulating liver injury.
@en
NOD2: a potential target for regulating liver injury.
@nl
prefLabel
NOD2: a potential target for regulating liver injury.
@en
NOD2: a potential target for regulating liver injury.
@nl
P2093
P2860
P50
P1476
NOD2: a potential target for regulating liver injury.
@en
P2093
Dana J Philpott
Dominique Berrebi
Emilie Gantier
Fabrice Chareyre
Filoména Conti
Gilles Pages
Irène Garcia
Marco Giovannini
Philippe J Sansonetti
Stephen E Girardin
P2860
P2888
P304
P356
10.1038/LABINVEST.3700716
P50
P577
2008-01-28T00:00:00Z